1Kimura Y, Matsuo M, Takahashi K, et al. ATP hydrolysis-dependent multidrug efflux transporter: MDR1/P-glycoprolein [J ]. Curr Drug Metab,2004,5(1) : 1 - 10.
2Akria T, Kumi T. Blood -brain barrier function of p -glycoprotein [J]. Drug Delivery Reviews, 1997,25:297.
3Lkumi T,Akira T. Drug delivery through the blood-brainbarrier[J ]. Advanced Drug Delivery Review, 1996,19 : 401.
4Schinkel AH, Wagenaar E, Mol CA, et al. P-glycoprotein in t hebloodbrain barrier of mice influences the brain penetration and phar-macological activity of many drugs[J]. J Clin Invest, 1996,97(11):2 517 - 2 524.
5Schinkel AH,Wagenaar E,Deernter LV,et al. Absen-ce of the mdrla P-proglyprotein in miceaffects tissuedistribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A[J]. J Clin Invest, 1995,96(4) : 1 698.
6De Lange EC,Marchand S, Van Den Berg D,et al. Invitro and in vivo investigations on fluoroquinolones, effects of the P-glyeoprotein elflux transporter on bra-in distribution of sparfloxaein [J]. Eur J Pharm Sci,2000,12(2) :85.
7Erik J, Hegmann HC, Bauger RO. Expression and functionactivity of p-glycoprotein in cultured cerberal capillaryendeothelial cells [ J ]. Cancer Reseach, 1992,52 : 6 969.
8Loscher W, Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family [ J ]. NeuroRx., 2005,2: 86-98.
9Tatsuta T, Naito M, Oh-ham T, et al. Functional involvement of Pglycoprotein in blood-brain barrier [J ]. J Biol Chem, 1992, 267: 20383 - 20391.
10Virgintino D, Robertson D,Errede M, et al. Expression of P-glycoprotein in human cerebral cortex microve.ssels[J ]. J HistochemCytochem, 2002,50:1 671 - 1 676.
8[1]VAN DEN HEUVEL-BIBRINK MM,SCONNEVELD P,PIETERS R.The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia[J].Clin Pharmacol Ther,2000,38(3):94-110.
9[2]ROCCHI E,VIGO J,VIALLET P,et al.Multiwavelength videomi-crofluorometric study of cytotixic effects of a marine peptide,didemnin B,on normal and MDR resistant CCRF-CME cell lines[J].Anticancer Res,2000,202A:987-986.
10[4]RAAIJ MAKERS HG,LZQUIERDO MA,LOKHORST HM,et al.Lung resistance related protein expression is a negative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma[J].Blood,1998,91(3):1029-1036.
